Genomic Testing and Tailored Therapies for Multiple Myeloma
At the 2018 Lymphoma & Myeloma congress, Joseph Mikhael, MD, MEd, FRCPC, Professor, Translational Genomics Research Institute, City of Hope Cancer Center, Phoenix, Arizona, spoke to Oncology Learning Network about genomic testing in multiple myeloma and how it can help clinicians personalize treatments for patients. He also shared his favorite analogy for using targeted therapy in this setting.
Check out the 3-part video series with Dr Mikhael below!
---
Genomic Tests Guide Therapy in Multiple Myeloma
Dr Mikhael discusses genomic tests and how they influence treatment choices for patients with multiple myeloma.
Challenges in Personalizing Therapy in Multiple Myeloma
Dr Mikhael discusses some of the challenges clinicians face in personalizing therapy for patients with multiple myeloma.
Targeting Multiple Myeloma: The Enemy Across the Street
Dr Mikhael shares an analogy in which he refers to multiple myeloma as "the enemy across the street."
